Latest News

Despite Grupo SBF S.A.'s ( BVMF:SBFG3 ) recent earnings report having lackluster headline numbers, the market responded...

While some are satisfied with an index fund, active investors aim to find truly magnificent investments on the stock...

In recent days, analysts issued upgrades and initiated positive coverage for Tarsus Pharmaceuticals, highlighting rapid commercialization of XDEMVY, the only approved treatment for Demodex blepharitis. An important insight is that analyst optimism centers around XDEMVY’s accelerating sales growth and significant untapped patient potential in the U.S. market. We’ll examine how renewed analyst confidence in XDEMVY’s rollout may influence Tarsus Pharmaceuticals’ growth and earnings outlook...

Innovent Biologics announced that its Phase 3 GLORY-2 clinical trial of mazdutide, a dual GCG/GLP-1 receptor agonist, in Chinese adults with obesity met all primary and secondary endpoints, and the company intends to submit a new drug application in China for weight management use. This marks mazdutide as the first innovative endocrinology and metabolic drug in China with clinical results published in The New England Journal of Medicine, highlighting its international scientific...

Federal Signal (FSS) has seen its shares decline nearly 14% over the past month, catching the attention of investors who follow the capital goods sector. The recent slide comes even as the company has reported steady growth in both revenue and net income. See our latest analysis for Federal Signal. While the past month’s roughly 14% pullback in Federal Signal’s share price has been hard to miss, it follows a period of much stronger performance over the longer term. The company’s 15% share...

V2X (VVX) just delivered record quarterly revenue and topped earnings estimates, which has caught investors’ attention following a busy week that also included board changes and a follow-on equity offering. The company also raised its full-year outlook for several key performance metrics. See our latest analysis for V2X. The upbeat earnings and outlook upgrades have helped V2X’s fundamentals shine, even as the company navigated board changes and a follow-on equity raise in recent days...

HNI (HNI) shares have traded quietly over the past week, giving investors a reason to review the fundamentals. Despite recent price dips, the company's strong 3-year total return stands out and warrants a closer look. See our latest analysis for HNI. While HNI’s share price has faced notable pressure lately, with a 1-month decline of 11.4% and a year-to-date drop of 20.4%, its 3-year total shareholder return of 47.3% suggests that long-term momentum remains intact despite some recent...

Earlier this week, Mizuho named First Industrial Realty Trust as a top real estate pick, citing its strong second-quarter results, diversified tenant base, and an improved outlook for fiscal 2025; the company also surpassed analyst expectations for third-quarter 2025 earnings. Analysts highlighted the company’s ability to accelerate the lease-up of projects under development, supported by a robust balance sheet and financial capacity for expansion. We’ll explore how this positive analyst...

HomeCo Daily Needs REIT recently declared a cash distribution of 2.15 cents per unit for the September 2025 quarter and completed acquisitions including a six-property retail portfolio for A$222 million and the Armstrong Creek Shopping Centre for A$55.6 million. These moves expand HDN’s exposure to high-growth population corridors with long-term leased assets, supporting consistent income and future development potential in Australia’s retail property sector. We'll explore how the recent...

On September 30, 2025, First Beijing Investment Ltd increased its holdings in New Oriental Education & Technology Group Inc by acquiring over 7 million shares, equating to a 4.07% rise in its stake. This move highlights growing institutional interest in New Oriental and emphasizes the company’s perceived long-term potential within the education and technology sectors. We’ll now explore how First Beijing’s substantial stake increase could shape New Oriental’s investment narrative going...

Turpaz Industries (TASE:TRPZ) released its third quarter and nine-month 2025 earnings, highlighting strong year-over-year sales growth and higher net income. Both of these factors caught the attention of investors looking for business expansion signals. See our latest analysis for Turpaz Industries. Turpaz Industries’ strong 2025 earnings have kept momentum on its side, with the share price surging 13.8% in the past month and delivering a staggering 199% year-to-date share price return. The...

Ever wondered if Fanuc's current price tag is a bargain or if you're better off waiting on the sidelines? You're not alone. We are about to dig into exactly what matters for value-focused investors. Fanuc has seen some notable moves lately, with the stock up 20.5% over the past year and a solid 18.5% gain year-to-date. However, it dipped 6.0% in the past week. Recent headlines have zeroed in on shifting investor expectations, as automation industry news points toward global supply chain...

Northern Star Resources recently held its Annual General Meeting, where shareholders approved the issuance of 403,466 performance rights to the CEO and confirmed key director re-elections. These moves, alongside strong FY24/25 results and the successful acquisition of De Grey Mining Ltd, underscore a focus on leadership stability and operational growth. The alignment of executive incentives with shareholder interests and progress on major projects like the Hemi Development Project could...

Cognex Corporation presented at the Stephens Annual Investment Conference in Nashville on November 19, 2025, highlighting its latest company updates and technological progress. Artisan Small Cap Fund recently reestablished its position in Cognex, attributing the move to a refreshed management approach, commitment to customer service, cost efficiency, and new AI-driven opportunities among previously unreachable customers. We'll explore how the fund's renewed investment and Cognex's AI...

Earlier this week, Agree Realty Corporation announced the closing of a US$350 million unsecured term loan maturing in 2031, featuring a fixed 4.02% interest rate and an accordion option to increase borrowing capacity up to US$500 million. This refinancing effort, which also included amendments to existing credit agreements, highlights the company’s proactive approach to managing debt costs and locking in favorable long-term funding conditions. We'll now explore how this new US$350 million...

Münchener Rückversicherungs-Gesellschaft in München recently reported past third-quarter earnings, with net income reaching €2.00 billion and basic earnings per share from continuing operations rising to €15.48, both substantially ahead of the prior year’s figures. The company has also continued its share buyback program, having repurchased a total of 2.35 million shares through the Frankfurt Stock Exchange since mid-May, highlighting management’s confidence in future prospects. We’ll...

Centessa Pharmaceuticals (NasdaqGS:CNTA) just completed a $250 million follow-on equity offering, issuing over 11 million new American Depositary Shares at $21.50 each with a $1.29 per share discount. This move expands the company's capital base and reflects management's approach to funding future projects. See our latest analysis for Centessa Pharmaceuticals. Centessa’s follow-on offering lands at a time when momentum is clearly building. The 30-day share price return stands at an impressive...

Saia (SAIA) shares have come under pressure recently, dropping over 21% in the past month. Investors may be weighing broader transportation trends and considering what they could mean for Saia's future revenue and profit growth. See our latest analysis for Saia. Saia's 1-year share price return is down sharply, falling more than 40%, and the total shareholder return over the same period is even steeper at -54%. Despite modest gains over longer timeframes, this recent slide suggests market...

Quest Diagnostics announced that its Board of Directors declared a quarterly cash dividend of US$0.80 per share, payable on January 28, 2026, to shareholders recorded as of January 13, 2026. Following third-quarter results that exceeded both revenue and earnings forecasts, the company also raised its full-year 2025 revenue outlook, signaling ongoing momentum in its core diagnostic testing business. We'll explore how Quest Diagnostics' strong financial performance and improved revenue...

Curious if Worthington Enterprises is a hidden gem or just fairly priced? You're not alone, as investors are watching closely to see if there's real value beneath the surface. The stock has had a rollercoaster month, dipping 5.1% in the past week and 8.2% over the last 30 days. Still, it's boasting a strong 34.8% gain year-to-date as well as a 34.6% return over the last year. Recent headlines around Worthington Enterprises have focused on broader industrial sector volatility and...

Tokyo Century (TSE:8439) has caught investor attention after revising its earnings guidance upward and announcing increased dividends for both the interim and full fiscal year. These changes reflect the company’s view of stronger financial performance ahead. See our latest analysis for Tokyo Century. The upbeat revisions to Tokyo Century’s profit and dividend forecasts have added fuel to a share price already on a strong run, with a year-to-date gain of more than 23%. Taking total shareholder...

Mesoblast Limited recently announced the appointment of James M. O’Brien as its new US-based Chief Financial Officer, drawing on his extensive financial leadership across global life sciences, biotechnology, and pharmaceutical companies. O’Brien’s expertise in orchestrating large-scale corporate transactions and public offerings brings significant operational and financial acumen to Mesoblast's transition into a fully integrated commercial organization. We’ll now explore how the addition of...

M&T Bank (MTB) shares have delivered mixed results this year, with returns slipping over the past 3 months. Investors are weighing the bank's steady growth in revenue and net income as they consider shifting market sentiment. See our latest analysis for M&T Bank. M&T Bank’s share price has lost momentum recently, with a 90-day share price return of -8.5 percent and a year-to-date dip of 3.2 percent. However, longer-term holders have still seen solid gains, as the bank’s five-year total...

Suruga Bank (TSE:8358) announced an increase to its second quarter-end and full-year dividend forecasts, and also provided new earnings guidance for the coming fiscal year. The higher dividend signals management’s outlook on growth and returns. See our latest analysis for Suruga Bank. Suruga Bank’s recent jump in quarterly and annual dividend forecasts has added fuel to investor optimism, sending the stock higher over the year. With a 38.5% share price return year-to-date and a remarkable...